⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for stage i uterine sarcoma

Every month we try and update this database with for stage i uterine sarcoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
Laparoscopic Surgery or Standard Surgery in Treating Patients With Endometrial Cancer or Cancer of the UterusNCT00002706
Endometrial Ade...
Stage I Uterine...
Stage I Uterine...
Stage II Uterin...
Stage II Uterin...
Laparoscopic Su...
Quality-of-Life...
Therapeutic Con...
18 Years - GOG Foundation
Radiation Therapy Compared With Combination Chemotherapy in Treating Patients With Cancer of the UterusNCT00002546
Sarcoma
cisplatin
ifosfamide
adjuvant therap...
radiation thera...
21 Years - 120 YearsGOG Foundation
Radiation Therapy or No Further Treatment Following Surgery in Treating Patients With Cancer of the UterusNCT00002459
Endometrial Can...
Sarcoma
radiation thera...
- European Organisation for Research and Treatment of Cancer - EORTC
T-Cell Response in Patients Receiving Trastuzumab and/or Chemotherapy for HER2-Positive Solid TumorsNCT00433407
Breast Cancer
Lung Cancer
Ovarian Cancer
Prostate Cancer
Sarcoma
Unspecified Adu...
trastuzumab
- Jonsson Comprehensive Cancer Center
Laparoscopic Surgery or Standard Surgery in Treating Patients With Endometrial Cancer or Cancer of the UterusNCT00002706
Endometrial Ade...
Stage I Uterine...
Stage I Uterine...
Stage II Uterin...
Stage II Uterin...
Laparoscopic Su...
Quality-of-Life...
Therapeutic Con...
18 Years - GOG Foundation
EF5 and Motexafin Lutetium in Detecting Tumor Cells in Patients With Abdominal or Non-Small Cell Lung CancerNCT00087191
Advanced Adult ...
Carcinoma of th...
Fallopian Tube ...
Gastrointestina...
Localized Extra...
Localized Gallb...
Localized Gastr...
Localized Resec...
Localized Unres...
Metastatic Gast...
Ovarian Sarcoma
Ovarian Stromal...
Primary Periton...
Recurrent Adult...
Recurrent Adult...
Recurrent Colon...
Recurrent Extra...
Recurrent Gallb...
Recurrent Gastr...
Recurrent Gastr...
Recurrent Non-s...
Recurrent Ovari...
Recurrent Ovari...
Recurrent Pancr...
Recurrent Recta...
Recurrent Small...
Recurrent Uteri...
Regional Gastro...
Small Intestine...
Small Intestine...
Small Intestine...
Stage 0 Non-sma...
Stage I Adult S...
Stage I Colon C...
Stage I Gastric...
Stage I Non-sma...
Stage I Ovarian...
Stage I Ovarian...
Stage I Pancrea...
Stage I Rectal ...
Stage I Uterine...
Stage II Adult ...
Stage II Colon ...
Stage II Gastri...
Stage II Non-sm...
Stage II Ovaria...
Stage II Ovaria...
Stage II Pancre...
Stage II Rectal...
Stage II Uterin...
Stage III Adult...
Stage III Colon...
Stage III Gastr...
Stage III Ovari...
Stage III Ovari...
Stage III Pancr...
Stage III Recta...
Stage III Uteri...
Stage IIIA Non-...
Stage IIIB Non-...
Stage IV Adult ...
Stage IV Colon ...
Stage IV Gastri...
Stage IV Non-sm...
Stage IV Ovaria...
Stage IV Ovaria...
Stage IV Pancre...
Stage IV Rectal...
Stage IV Uterin...
Unresectable Ex...
Unresectable Ga...
EF5
motexafin lutet...
pharmacological...
18 Years - National Cancer Institute (NCI)
Liposomal Doxorubicin and Carboplatin in Treating Patients With Gynecologic CancerNCT00032162
Cervical Cancer
Endometrial Can...
Fallopian Tube ...
Ovarian Cancer
Sarcoma
carboplatin
pegylated lipos...
18 Years - AGO Study Group
Thalidomide in Treating Patients With Gynecologic SarcomasNCT00006005
Endometrial Can...
Sarcoma
thalidomide
- National Cancer Institute (NCI)
Patient, Physician, and Nurse Factors Associated With Entry Onto Clinical Trials and Finishing Treatment in Patients With Primary or Recurrent Uterine, Endometrial, or Cervical CancerNCT01098630
Recurrent Cervi...
Recurrent Uteri...
Recurrent Uteri...
Stage I Uterine...
Stage I Uterine...
Stage IA Cervic...
Stage IB Cervic...
Stage II Uterin...
Stage II Uterin...
Stage IIA Cervi...
Stage IIB Cervi...
Stage III Cervi...
Stage III Uteri...
Stage III Uteri...
Stage IV Uterin...
Stage IV Uterin...
Stage IVA Cervi...
Stage IVB Cervi...
Medical Chart R...
Questionnaire A...
- GOG Foundation
Low-Residue Diet in Treating Diarrhea in Patients Receiving Pelvic Radiation Therapy.NCT00258401
Cervical Cancer
Diarrhea
Prostate Cancer
Radiation Toxic...
Sarcoma
dietary interve...
management of t...
quality-of-life...
20 Years - 80 YearsCase Comprehensive Cancer Center
Low-Residue Diet in Treating Diarrhea in Patients Receiving Pelvic Radiation Therapy.NCT00258401
Cervical Cancer
Diarrhea
Prostate Cancer
Radiation Toxic...
Sarcoma
dietary interve...
management of t...
quality-of-life...
20 Years - 80 YearsCase Comprehensive Cancer Center
Cyproheptadine in Preventing Weight Loss in Children Receiving Chemotherapy for CancerNCT01132547
Cancer
cyproheptadine ...
placebo
2 Years - 21 YearsUniversity of South Florida
Amifostine in Treating Women With Ovarian, Peritoneal, Cervical, Fallopian Tube, Uterine, or Endometrial CancerNCT00003624
Cervical Cancer
Endometrial Can...
Fallopian Tube ...
Neurotoxicity
Ovarian Cancer
Primary Periton...
Sarcoma
amifostine trih...
cisplatin
paclitaxel
- GOG Foundation
Amifostine in Treating Women With Ovarian, Peritoneal, Cervical, Fallopian Tube, Uterine, or Endometrial CancerNCT00003624
Cervical Cancer
Endometrial Can...
Fallopian Tube ...
Neurotoxicity
Ovarian Cancer
Primary Periton...
Sarcoma
amifostine trih...
cisplatin
paclitaxel
- GOG Foundation
Improving Employment in Patients Who Have Survived Cervical Cancer, Uterine Cancer, or Ovarian CancerNCT00383279
Cervical Cancer
Ovarian Cancer
Sarcoma
counseling inte...
study of socioe...
18 Years - 120 YearsWake Forest University Health Sciences
Psychosexual Intervention in Patients With Stage I-III Gynecologic or Breast CancerNCT01764802
Ovarian Sarcoma
Ovarian Stromal...
Stage I Uterine...
Stage I Vaginal...
Stage I Vulvar ...
Stage IA Cervic...
Stage IA Endome...
Stage IA Fallop...
Stage IA Ovaria...
Stage IA Ovaria...
Stage IA Primar...
Stage IB Cervic...
Stage IB Endome...
Stage IB Fallop...
Stage IB Ovaria...
Stage IB Ovaria...
Stage IB Primar...
Stage IC Fallop...
Stage IC Ovaria...
Stage IC Ovaria...
Stage IC Primar...
Stage II Endome...
Stage II Gestat...
Stage II Uterin...
Stage II Vagina...
Stage II Vulvar...
Stage IIA Cervi...
Stage IIA Fallo...
Stage IIA Ovari...
Stage IIA Ovari...
Stage IIA Prima...
Stage IIB Cervi...
Stage IIB Fallo...
Stage IIB Ovari...
Stage IIB Ovari...
Stage IIB Prima...
Stage IIC Fallo...
Stage IIC Ovari...
Stage IIC Ovari...
Stage IIC Prima...
Stage III Gesta...
Stage III Uteri...
Stage III Vagin...
Stage III Vulva...
Stage IIIA Cerv...
Stage IIIA Endo...
Stage IIIA Fall...
Stage IIIA Ovar...
Stage IIIA Ovar...
Stage IIIA Prim...
Stage IIIB Cerv...
Stage IIIB Endo...
Stage IIIB Fall...
Stage IIIB Ovar...
Stage IIIB Ovar...
Stage IIIB Prim...
Stage IIIC Endo...
Stage IIIC Fall...
Stage IIIC Ovar...
Stage IIIC Ovar...
Stage IIIC Prim...
Breast Cancer
behavioral, psy...
behavioral, psy...
21 Years - 80 YearsOhio State University Comprehensive Cancer Center
Thalidomide in Treating Patients With Gynecologic SarcomasNCT00006005
Endometrial Can...
Sarcoma
thalidomide
- National Cancer Institute (NCI)
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: